The American Society for Gastrointestinal Endoscopy recently released new clinical guidance on the screening for pancreatic cancer in people with genetic susceptibility (Gastrointest Endosc 2022 Feb 16. doi:10.1016/j.gie.2021.12.001). GEN’s Sarah Tilyou spoke with lead author Mandeep S. Sawhney, MD, MS, FASGE, a gastroenterologist at Beth Israel Deaconess Medical Center and an associate professor of medicine at Harvard Medical School, in Boston, about the impetus for the guidelines and what they mean to GI practice.
Trending
- Behavioral Interventions Improve Mailed Colorectal Cancer Screening Among Overdue Patients in a Randomized Trial (CGH Journal)
- Leading efforts in insurance oversight (AGA)
- Different outcomes of AI-read vs human-read endoscopies in the TITRATE study (Medicom)
- Firefly-Inspired Pill Lights Up the Gut To Reveal Inflammation (Technology Networks)
- Private equity investment: Could it help physicians? (Medical Economics)
- Olympus execs talk about import alert, GI robot and AI (Medtech Dive)
- Breath Test for MASH/MASLD Shows Promise in Pilot Study (GI & Endoscopy News)
- With A Doctor Shortage; Is Concierge Medicine Morally Acceptable? (Forbes)
